Overview: The maturing of proteomics in cardiovascular research

Circulation Research

Volumn 108, Issue 4, 2011, Pages 490-498

  Van Eyk, Jennifer E ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

polymorphism; posttranslational modification; protein isoform; proteomics; technology

Indexed keywords

AMINO ACID; HEART PROTEIN; PROTEIN; PROTEOME; UNCLASSIFIED DRUG;

HUMAN; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROCESSING; PROTEOMICS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; BIOMEDICAL RESEARCH; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOMICS;

EID: 79952064739     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.110.226894     Document Type: Review

References (99)

1. Gundry RL, Tchernyshyov I, Sheng S, Tarasova Y, Raginski K, Boheler KR, Van Eyk JE. Expanding the mouse embryonic stem cell proteome: combining three proteomic approaches. Proteomics. 2010;10:2728-2732.
2. Warren CM, Geenen DL, Helseth DL Jr, Xu H, Solaro RJ. Sub-proteomic fractionation, iTRAQ, and OFFGEL-LC-MS/MS approaches to cardiac proteomics. J Proteomics. 2010;73:1551-1561.
3. Bousette N, Kislinger T, Fong V, Isserlin R, Hewel JA, Emil A, Gramolini AO. Large-scale characterization and analysis of the murine cardiac proteome. J Proteome Res. 2009;8:1887-1901.
4. Callipo L, Capriotti AL, Cavaliere C, Gubbiotti R, Samperi R, Laganà A. Evaluation of different two-dimensional chromatographic techniques for proteomic analysis of mouse cardiac tissue. Biomed Chromatogr. 2010 Jul 22 [Epub ahead of print] PubMed PMID: 20652868.
5. Duan X, Young R, Straubinger RM, Page B, Cao J, Wang H, Yu H, Canty JM, Qu J. A straightforward and highly efficient precipitation/on-pellet digestion procedure coupled with a long gradient nano-LC separation and Orbitrap mass spectrometry for label-free expression profiling of the swine heart mitochondrial proteome. Proteome Res. 2009;8:2838-2850.
6. Drews O, Zong C, Ping P. Exploring proteasome complexes by proteomic approaches. Proteomics. 2007;7:1047-1058. (Pubitemid 46649154)
7. Gomes AV, Zong C, Edmondson RD, Li X, Stefani E, Zhang J, Jones RC, Thyparambil S, Wang GW, Qiao X, Bardag-Gorce F, Ping P. Mapping the murine cardiac 26S proteasome complexes. Circ Res. 2006;99:362-371. (Pubitemid 44253692)
8. Neverova I, Van Eyk JE. Application of reversed phase high performance liquid chromatography for subproteomic analysis of cardiac muscle. Proteomics. 2002;2:22-31. (Pubitemid 34273095)
9. McDonald T, Sheng S, Stanley B, Chen D, Ko Y, Cole RN, Pedersen P, Van Eyk JE. Expanding the subproteome of the inner mitochondria using protein separation technologies: one- and two-dimensional liquid chromatography and two-dimensional gel electrophoresis. Mol Cell Proteomics. 2006;5:2392-2411. (Pubitemid 46040643)
10. Taylor SW, Warnock DE, Glenn GM, Zhang B, Fahy E, Gaucher SP, Capaldi RA, Gibson BW, Ghosh SS. An alternative strategy to determine the mitochondrial proteome using sucrose gradient fractionation and 1D PAGE on highly purified human heart mitochondria. J Proteome Res. 2002;1:451-458. (Pubitemid 36395864)
11. Ouyang Y, Mamidi R, Jayasundar JJ, Chandra M, Dong WJ. Structural and kinetic effects of PAK3 phosphorylation mimic of cTnI(S151E) on the cTnC-cTnI interaction in the cardiac thin filament. J Mol Biol. 2010;400:1036-1045.
12. Sumandea MP, Rybin VO, Hinken AC, Wang C, Kobayashi T, Harleton E, Sievert G, Balke CW, Feinmark SJ, Solaro RJ, Steinberg SF. Tyrosine phosphorylation modifies protein kinase C delta-dependent phosphorylation of cardiac troponin I. J Biol Chem. 2008;283:22680-22689.
13. Zabrouskov V, Ge Y, Schwartz J, Walker JW. Unraveling molecular complexity of phosphorylated human cardiac troponin I by top down electron capture dissociation/electron transfer dissociation mass spectrometry. Mol Cell Proteomics. 2008;7:1838-1849.
14. Gallon CE. Current techniques for the study of troponin I phosphorylation in human heart. J Muscle Res Cell Motil. 2008;29:169-172.
15. McDonough JL, Arrell DK, Van Eyk JE. Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury. Circ Res. 1999;84:9-20. (Pubitemid 29074876)
16. Feng J, Schaus BJ, Fallavollita JA, Lee TC, Canty JM Jr. Preload induces troponin I degradation independently of myocardial ischemia. Circulation. 2001;103:2035-2037. (Pubitemid 32373003)
17. Ramirez-Correa GA, Jin W, Wang Z, Zhong X, Gao WD, Dias WB, Vecoli C, Hart GW, Murphy AM. O-linked GlcNAc modification of cardiac myofilament proteins: a novel regulator of myocardial contractile function. Circ Res. 2008;103:1354-1358.
18. Kositprapa C, Zhang B, Berger S, Canty JM Jr, Lee TC. Calpain-mediated proteolytic cleavage of troponin I induced by hypoxia or metabolic inhibition in cultured neonatal cardiomyocytes. Mol Cell Biochem. 2000;214:47-55. (Pubitemid 32010325)
19. Murphy AM, Kögler H, Georgakopoulos D, McDonough JL, Kass DA, Van Eyk JE, Marbán E. Transgenic mouse model of stunned myocardium. Science. 2000;287:488-491.
20. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, Mann M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics. 2002;1:376-386.
21. MacGillivray AJ, Rickwood D. The heterogeneity of mouse-chromatin nonhistone proteins as evidenced by two-dimensional polyacrylamide-gel electrophoresis and ion-exchange chromatography. Eur J Biochem. 1974;41:181-190.
22. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem. 1975;250:4007-4021.
23. Rabilloud T, Chevallet M, Luche S, Lelong C. Two-dimensional gel electrophoresis in proteomics: past, present and future. J Proteomics. 2010;73:2064-2077.
24. Chevalier F. Highlights on the capacities of "gel-based" proteomics. Proteome Sci. 2010;8:23-26.
25. Rabilloud T. Variations on a theme: changes to electrophoretic separations that can make a difference. J Proteomics. 2010;73:1562-1572.
26. Friedman DB, Hoving S, Westermeier R. Westermeier R, Schickle H. The current state of the art in high-resolution two-dimensional electrophoresis. Methods Enzymol. 2009;463:305-328.
27. Neverova I, Van Eyk JE. Role of chromatographic techniques in proteomic analysis. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;815:51-63. (Pubitemid 40136519)
28. Horvatovich P, Hoekman B, Govorukhina N, Bischoff R. Multidimensional chromatography coupled to mass spectrometry in analysing complex proteomics samples. J Sep Sci. 2010;33:1421-1437.
29. Tomás R, Klepárník K, Foret F. Multidimensional liquid phase separations for mass spectrometry. J Sep Sci. 2008;31:1964-1979. (Pubitemid 352003181)
30. Mitulovic G, Mechtler K. HPLC techniques for proteomics analysis-a short overview of latest developments. Brief Funct Genomic Proteomic. 2006;5:249-260. (Pubitemid 46404129)
31. Guo Y, Ma SF, Grigoryev D, Van Eyk J, Garcia JG. 1-DE MS and 2-D LC-MS analysis of the mouse bronchoalveolar lavage proteome. Proteomics. 2005;5:4608-4624. (Pubitemid 41739938)
32. Sheng S, Chen D, Van Eyk JE. Multidimensional liquid chromatography separation of intact proteins by chromatographic focusing and reversed phase of the human serum proteome: optimization and protein database. Mol Cell Proteomics. 2006;5:26-34. (Pubitemid 43169337)
33. Berglund L, Björling E, Oksvold P, Fagerberg L, Asplund A, Szigyarto CA, Persson A, Ottosson J, Wernérus H, Nilsson P, Lundberg E, Sivertsson A, Navani S, Wester K, Kampf C, Hober S, Pontén F, Uhlén M. Gene-centric human protein atlas for expression profiles based on antibodies. Mol Cell Proteomics. 2008;7:2019-2027.
34. Nilsson P, Paavilainen L, Larsson K, Odling J, Sundberg M, Andersson AC, Kampf C, Persson A, Al-Khalili Szigyarto C, Ottosson J, Björling E, Hober S, Wernérus H, Wester K, Pontén F, Uhlen M. Towards a human proteome atlas: high-throughput generation of mono-specific antibodies for tissue profiling. Proteomics. 2005;5:4327-4337. (Pubitemid 41739911)
35. Voshol H, Ehrat M, Traenkle J, Bertrand E, van Oostrum. Antibody-based proteomics: analysis of signaling networks using reverse protein arrays. J FEBS. 2009;276:6871-6879.
36. Sharp V, Utz PJ. Technology insight: can autoantibody profiling improve clinical practice? Nat Clin Pract Rheumatol. 2007;3:96-103.
37. Uhlén M, Hober S. Generation and validation of affinity reagents on a proteome-wide level. J Mol Recognit. 2009;22:57-64.
38. Kodadek T. Synthetic receptors with antibody-like binding affinities. Curr Opin Chem Biol. 2010;4:713-720.
39. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, Khainovski N, Pillai S, Dey S, Daniels S, Purkayastha S, Juhasz P, Martin S, Bartlet-Jones M, He F, Jacobson A, Pappin DJ. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics. 2004;3:1154-1169.
40. Thompson A, Schäfer J, Kuhn K, Kienle S, Schwarz J, Schmidt G, Neumann T, Johnstone R, Mohammed AK, Hamon C. Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal Chem. 2003;75:1895-1904. (Pubitemid 36438013)
41. Bantscheff M, Schirle M, Sweetman G, Rick J, Kuster B. Quantitative mass spectrometry in proteomics: a critical review. Anal Bioanalytical Chem. 2007;389:1017-1031. (Pubitemid 47482251)
42. Kitteringham NR, Jenkins RE, Lane CS, Elliott VL, Park BK. Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics. J Chromatogr B Analyt Technol Biomed Life Sci. 2008;877:1229-1239.
43. Fortin T, Salvador A, Charrier JP, Lenz C, Lacoux X, Morla A, Choquet- Kastylevsky G, Lemoine J. Clinical quantitation of prostate specific antigen biomarker in the low nanogram/mL range by conventional bore liquid chromatography-tandem mass spectrometry (MRM) coupling and correlation with ELISA tests. Mol Cell Proteomics. 2009;8:1006-1015.
44. DeSouza LV, Taylor AM, Li W, Minkoff MS, Romaschin AD, Colgan TJ, Siu KW. Multiple reaction monitoring of mTRAQ-labeled peptides enables absolute quantification of endogenous levels of a potential cancer marker in cancerous and normal endometrial tissues. J Proteome Res. 2008;7:3525-3534.
45. Kuhn E. Wu J, Karl J, Liao H, Zolg W, Guild B. Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards. Proteomics. 2004;4:1175-1186. (Pubitemid 38445974)
46. Anderson L, Hunter CL. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics. 2006;5:573-588.
47. Fu Q, Schoenhoff FS, Savage WJ, Zhang P, Van Eyk JE. Multiplex assays for biomarker research and clinical application: translational science coming of age. Proteomics Clin Appl. 2010;4:271-284.
48. Palmisano G, Thingholm TE. Strategies for quantitation of phosphoproteomic data. Expert Rev Proteomics. 2010;7:439-456.
49. Grimsrud PA, Swaney DL, Wenger CD, Beauchene NA, Coon JJ. Phosphoproteomics for the masses. ACS Chem Biol. 2010;5:105-119.
50. Lemeer S, Heck AJ. The phosphoproteomics data explosion. Curr Opin Chem Biol. 2009;13:414-420.
51. Agnetti G, Kaludercic N, Kane LA, Elliott ST, Guo Y, Chakir K, Samantapudi D, Paolocci N, Tomaselli GF, Kass DA, Van Eyk JE. Modulation of mitochondrial proteome and improved mitochondrial function by biventricular pacing of dyssynchronous failing hearts. Circ Cardiovasc Genet. 2010;3:78-87.
52. Matt P, Fu Z, Carrel T, Huso DL, Dirnhofer S, Lefkovits I, Zerkowski HR, Van Eyk JE. Proteomic alterations in heat shock protein 27 and identification of phosphoproteins in ascending aortic aneurysm associated with bicuspid and tricuspid aortic valve. J Mol Cell Cardiol. 2007;43:792-801. (Pubitemid 350166379)
53. Martin K, Steinberg TH, Goodman T, Schulenberg B, Kilgore JA, Gee KR, Beechem JM, Patton WF. Strategies and solid-phase formats for the analysis of protein and peptide phosphorylation employing a novel fluorescent phosphorylation sensor dye. Comb Chem High Throughput Screen. 2003;6:331-339. (Pubitemid 36612351)
54. Kinoshita E, Kinoshita-Kikuta E, Takiyama K, Koike T. Phosphate-binding tag, a new tool to visualize phosphorylated proteins. Mol Cell Proteomics. 2006;5:749-757.
55. Yuan C, Sheng Q, Tang H, Li Y, Zeng R, Solaro RJ. Quantitative comparison of sarcomeric phosphoproteomes of neonatal and adult rat hearts. Am J Physiol Heart Circ Physiol. 2008;295:H647-H656.
56. Lu H, Zong C, Wang Y, Young GW, Deng N, Souda P, Li X, Whitelegge J, Drews O, Yang PY, Ping P. Revealing the dynamics of the 20 S proteasome phosphoproteome: a combined CID and electron transfer dissociation approach. Mol Cell Proteomics. 2008;7:2073-2089.
57. Deng N, Zhang J, Zong C, Wang Y, Lu H, Yang P, Wang W, Young GW, Wang Y, Korge P, Lotz C, Doran P, Liem DA, Apweiler R, Weiss JN, Duan H, Ping P. Phosphoproteome analysis reveals regulatory sites in major pathways of cardiac mitochondria. Mol Cell Proteomics. 2010 Sep 7 [Epub ahead of print] PubMed PMID: 20495213.
58. Aponte AM, Phillips D, Hopper RK, Johnson DT, Harris RA, Blinova K, Boja ES, French S, Balaban RS. Use of (32)P to study dynamics of the mitochondrial phosphoproteome. J Proteome Res. 2009;8:2679-2695.
59. Feng J, Zhu M, Schaub MC, Gehrig P, Roschitzki B, Lucchinetti E, Zaugg M. Phosphoproteome analysis of isoflurane-protected heart mitochondria: phosphorylation of adenine nucleotide translocator-1 on Tyr194 regulates mitochondrial function. Cardiovasc Res. 2008;80:20-29.
60. Chu G, Egnaczyk GF, Zhao W, Jo SH, Fan GC, Maggio JE, Xiao RP, Kranias EG. Phosphoproteome analysis of cardiomyocytes subjected to beta-adrenergic stimulation: identification and characterization of a cardiac heat shock protein p20. Circ Res. 2004;94:184-193. (Pubitemid 38197450)
61. Holt GD, Hart GW. The subcellular distribution of terminal N-acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc. J Biol Chem. 1986;261:8049-8057. (Pubitemid 17208742)
62. Wells L, Hart GW. O-GlcNAc turns twenty: functional implications for post-translational modification of nuclear and cytosolic proteins with a sugar. FEBS Lett. 2003;546:154-158. (Pubitemid 36782297)
63. Ngoh GA, Hamid T, Prabhu SD, Jones SP. Increased O-linked beta- Nacetylglucosamine levels on proteins improves survival, reduces inflammation and organ damage 24 hours after trauma-hemorrhage in rats. Am J Physiol Heart Circ Physiol. 2009;297:H1711-H1719.
64. Wang Z, Gucek M, Hart GW. Cross-talk between GlcNAcylation and phosphorylation: site-specific phosphorylation dynamics in response to globally elevated O-GlcNAc. Proc Natl Acad Sci U S A. 2008;105:13793-13798.
65. Copeland RJ, Bullen JW, Hart GW. Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. Am J Physiol Endocrinol Metab. 2008;295:E17-E28.
66. Hart GW, Housley MP, Slawson C. Cycling of O-linked beta- Nacetylglucosamine on nucleocytoplasmic proteins. Nature. 2007;446:1017-1022. (Pubitemid 46676063)
67. Wang Z, Pandey A, Hart GW. Dynamic interplay between O-linked N-acetylglucosaminylation and glycogen synthase kinase-3-dependent phosphorylation. Mol Cell Proteomics. 2007;6:1365-1379. (Pubitemid 47365435)
68. Whelan SA, Lane MD, Hart GW. Regulation of the O-linked beta- Nacetylglucosamine transferase by insulin signaling. J Biol Chem. 2008;283:21411-21417.
69. Song M, Kim HS, Park JM, Kim SH, Kim IH, Ryu SH, Suh PG. O-GlcNAc transferase is activated by CaMKIV-dependent phosphorylation under potassium chloride-induced depolarization in NG-108-15 cells. Cell Signal. 2008;20:94-104. (Pubitemid 350148250)
70. Watson LJ, Facundo HT, Ngoh GA, Ameen M, Brainard RE, Lemma KM, Long BW, Prabhu SD, Xuan YT, Jones SP. O-linked -Nacetylglucosamine transferase is indispensable in the failing heart. Proc Natl Acad Sci U S A. 2010;107:17797-17802.
71. Marsh SA, Dell'italia LJ, Chatham JC. Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice. Amino Acids. 2010 Jul 30 [Epub ahead of print] PubMed PMID: 20676904; PubMed Central PMCID: PMC3025273.
72. Yokoe S, Asahi M, Takeda T, Otsu K, Taniguchi N, Miyoshi E, Suzuki K. Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy. Glycobiology. 2010;20:1217-1226.
73. WuT, Zhou H, Jin Z, Bi S, Yang X, Yi D, Liu W. Cardioprotection of salidroside from ischemia/reperfusion injury by increasing N-acetylglucosamine linkage to cellular proteins. Eur J Pharmacol. 2009;613:93-99.
74. Zou L, Yang S, Champattanachai V, Hu S, Chaudry IH, Marchase RB, Chatham JC. Glucosamine improves cardiac function following trauma-hemorrhage by increased protein O-GlcNAcylation and attenuation of NF-{kappa}B signaling. Am J Physiol Heart Circ Physiol. 2009;296:H515-H523.
75. Hu Y, Suarez J, Fricovsky E, Wang H, Scott BT, Trauger SA, Han W, Hu Y, Oyeleye MO, Dillmann WH. Increased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucose. J Biol Chem. 2009;284:547-555.
76. Fülöp N, Feng W, Xing D, He K, Not LG, Brocks CA, Marchase RB, Miller AP, Chatham JC. Aging leads to increased levels of protein O-linked N-acetylglucosamine in heart, aorta, brain and skeletal muscle in Brown-Norway rats. Biogerontology. 2008;9:139-151.
77. Ngoh GA, Facundo HT, Zafir A, Jones SP. O-GlcNAc signaling in the cardiovascular system. Circ Res. 2010;107:171-185.
78. Chatham JC, Marchase RB. The role of protein O-linked beta- Nacetylglucosamine in mediating cardiac stress responses. Biochim Biophys Acta. 2010;1800:57-66.
79. Laczy B, Hill BG, Wang K, Paterson AJ, White CR, Xing D, Chen YF, Darley-Usmar V, Oparil S, Chatham JC. Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system. Am J Physiol Heart Circ Physiol. 2009;296:H13-H28.
80. Rexach JE, Rogers CJ, Yu SH, Tao J, Sun YE, Hsieh-Wilson LC. Quantification of O-glycosylation stoichiometry and dynamics using resolvable mass tags. Nat Chem Biol. 2010;6:645-651.
81. Wang Z, Udeshi ND, O'Malley M, Shabanowitz J, Hunt DF, Hart GW. Enrichment and site mapping of O-linked N-acetylglucosamine by a combination of chemical/enzymatic tagging, photochemical cleavage, and electron transfer dissociation mass spectrometry. Mol Cell Proteomics. 2010;9:153-160.
82. Zachara NE, Cole RN, Hart GW, Gao Y. Detection and analysis of proteins modified by O-linked N-acetylglucosamine. Curr Protoc Protein Sci. 2001;Chapter 12:Unit 12.8.
83. Wells L, Vosseller K, Cole RN, Cronshaw JM, Matunis MJ, Hart GW. Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications. Mol Cell Proteomics. 2002;1:791-804.
84. Hu P, Shimoji S, Hart GW. Site-specific interplay between O-GlcNAcylation and phosphorylation in cellular regulation. Mol Biol Cell. 2010;21:1922-1936.
85. Zeidan Q, Hart GW. The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways. J Cell Sci. 2010;123:13-22.
86. Foster DB, Van Eyk JE, Marbán E, O'Rourke B. Redox signaling and protein phosphorylation in mitochondria: progress and prospects. J Bioenerg Biomembr. 2009;41:159-168.
87. Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, Mathivanan S, Telikicherla D, Raju R, Shafreen B, Venugopal A, Balakrishnan L, Marimuthu A, Banerjee S, Somanathan DS, Sebastian A, Rani S, Ray S, Harrys Kishore CJ, Kanth S, Ahmed M, Kashyap MK, Mohmood R, Ramachandra YL, Krishna V, Rahiman BA, Mohan S, Ranganathan P, Ramabadran S, Chaerkady R, Pandey A. Human Protein Reference Database-2009 Update. Nucleic Acids Research. 2009;37:D767-D772.
88. Han G, Ye M, Liu H, Song C, Sun D, Wu Y, Jiang X, Chen R, Wang C, Wang L, Zou H. Phosphoproteome analysis of human liver tissue by long-gradient nanoflow LC coupled with multiple stage MS analysis. Electrophoresis. 2010;31:1080-1089.
89. Olsen JV, Vermeulen M, Santamaria A, Kumar C, Miller ML, Jensen LJ, Gnad F, Cox J, Jensen TS, Nigg EA, Brunak S, Mann M. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010;3:ra3.
90. Patterson SD, Van Eyk JE, Banks RE. Report from the Wellcome Trust/EBA "Perspectives in Clinical Proteomics" retreat-a strategy to implement next-generation proteomic analyses to the clinic for patient benefit: pathway to translation. Proteomics Clin Appl. 2010;4:883-887.
91. Edwards A. Large-scale structural biology of the human proteome. Annu Rev Biochem. 2009;78:541-568.
92. Terwilliger TC, Stuart D, Yokoyama S. Lessons from structural genomics. Annu Rev Biophys. 2009;38:371-383.
93. Perera M, Tsang CS, Distel RJ, Lacy JN, Ohno-Machado L, Ricchiuti V, Samaranayake LP, Smejkal GB, Smith MG, Trachtenberg AJ, Kuo WP. TGF-beta1 interactome: metastasis and beyond. Cancer Genomics Proteomics. 2010;7:217-229.
94. Scholten A, Poh MK, van Veen TA, van Breukelen B, Vos MA, Heck AJ. cAMP interactome using a chemical proteomics approach in mammalian heart tissue validates sphingosine kinase type 1-interacting protein as a genuine and highly abundant AKAP. J Proteome Res. 2006;5:1435-1447. (Pubitemid 43870042)
95. Roy J, Cyert MS. Cracking the phosphatase code: docking interactions determine substrate specificity. Sci Signal. 2009;2:re9.
96. De Las Rivas J, de Luis A. Interactome data and databases: different types of protein interaction. Comp Funct Genomics. 2004;5:173-178. (Pubitemid 38744654)
97. Vedadi M, Arrowsmith CH, Allali-Hassani A, Senisterra G, Wasney GA. Biophysical characterization of recombinant proteins: a key to higher structural genomics success. J Struct Biol. 2010;172:107-119.
98. Fero M, Pogliano K. Automated quantitative live cell fluorescence microscopy. Cold Spring Harb Perspect Biol. 2010;2:a000455.
99. Hamilton NA, Teasdale RD. Visualizing and clustering high throughput sub-cellular localization imaging. BMC Bioinformatics. 2008;9:81.